Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank25
Studio
Year-over-Year Change

Return on invested capital

Percentile
P25
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025-178.22%+89.3%
2024-1662.28%-1392.4%
2023-111.38%-146.4%
2022240.27%+44.6%
2021166.16%-